{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:21:24Z","timestamp":1779200484189,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00109-023-02291-x","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T16:53:58Z","timestamp":1677171238000},"page":"375-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Novel read through agent: ZKN-0013 demonstrates efficacy in APCmin model of familial adenomatous polyposis"],"prefix":"10.1007","volume":"101","author":[{"given":"Martin R.","family":"Graf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Apte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Terzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simran","family":"Padhye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan K.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger B.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Modur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3593-966X","authenticated-orcid":false,"given":"Vasudeo","family":"Badarinarayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"2291_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-4-22","volume":"4","author":"E Half","year":"2009","unstructured":"Half E, Bercovich D, Rozen P (2009) Familial adenomatous polyposis. Orphanet J Rare Dis 4:22","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"2291_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/hmg\/10.7.721","volume":"10","author":"NS Fearnhead","year":"2001","unstructured":"Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10(7):721\u2013733","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2291_CR3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3892\/or.2013.2681","volume":"30","author":"LB De Queiroz Rossanese","year":"2013","unstructured":"De Queiroz Rossanese LB, De Lima Marson FA, Ribeiro JD, Coy CS, Bertuzzo CS (2013) APC germline mutations in families with familial adenomatous polyposis. Oncol Rep 30(5):2081\u20132088","journal-title":"Oncol Rep"},{"key":"2291_CR4","first-page":"95","volume":"8","author":"ML Leoz","year":"2015","unstructured":"Leoz ML, Carballal S, Moreira L, Ocana T, Balaguer F (2015) The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl Clin Genet 8:95\u2013107","journal-title":"Appl Clin Genet"},{"issue":"1","key":"2291_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0959-437X(95)90055-1","volume":"5","author":"P Polakis","year":"1995","unstructured":"Polakis P (1995) Mutations in the APC gene and their implications for protein structure and function. Curr Opin Genet Dev 5(1):66\u201371","journal-title":"Curr Opin Genet Dev"},{"issue":"10","key":"2291_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.ejhg.5200853","volume":"10","author":"R Ripa","year":"2002","unstructured":"Ripa R, Bisgaard ML, Bulow S, Nielsen FC (2002) De novo mutations in familial adenomatous polyposis (FAP). Eur J Hum Genet 10(10):631\u2013637","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"2291_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1572-0241.2006.00375.x","volume":"101","author":"P Galiatsatos","year":"2006","unstructured":"Galiatsatos P, Foulkes WD (2006) Familial adenomatous polyposis. Am J Gastroenterol 101(2):385\u2013398","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2291_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1447-073x.2005.00106.x","volume":"80","author":"T Senda","year":"2005","unstructured":"Senda T, Shimomura A, Iizuka-Kogo A (2005) Adenomatous polyposis coli (Apc) tumor suppressor gene as a multifunctional gene. Anat Sci Int 80(3):121\u2013131","journal-title":"Anat Sci Int"},{"key":"2291_CR9","doi-asserted-by":"crossref","unstructured":"Hankey W, Frankel WL, Groden J\u00a0(2018) Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.\u00a0Cancer Metastasis Rev 37(1):159\u2013172","DOI":"10.1007\/s10555-017-9725-6"},{"key":"2291_CR10","doi-asserted-by":"crossref","unstructured":"Khalilzadeha S, Pakdaman SF, Momeni-Moghaddam M\u00a0(2016) The role of APC in Wnt\/ \u03b2-catenin pathway in gastric cancer.\u00a0The Cancer Press 2(3)","DOI":"10.15562\/tcp.24"},{"issue":"5382","key":"2291_CR11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"TC He","year":"1998","unstructured":"He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281(5382):1509\u20131512","journal-title":"Science"},{"issue":"1","key":"2291_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/nar\/24.1.121","volume":"24","author":"C Beroud","year":"1996","unstructured":"Beroud C, Soussi T (1996) APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 24(1):121\u2013124","journal-title":"Nucleic Acids Res"},{"issue":"57","key":"2291_CR13","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1038\/sj.onc.1210059","volume":"25","author":"S Segditsas","year":"2006","unstructured":"Segditsas S, Tomlinson I (2006) Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25(57):7531\u20137537","journal-title":"Oncogene"},{"issue":"3","key":"2291_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000066755","volume":"66","author":"FT Kolligs","year":"2002","unstructured":"Kolligs FT, Bommer G, Goke B (2002) Wnt\/beta-catenin\/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66(3):131\u2013144","journal-title":"Digestion"},{"issue":"1","key":"2291_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","volume":"10","author":"SG Pai","year":"2017","unstructured":"Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles FJ (2017) Wnt\/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol 10(1):101","journal-title":"J Hematol Oncol"},{"key":"2291_CR16","doi-asserted-by":"crossref","unstructured":"Bian J, Dannappel M, Wan C, Firestein R\u00a0(2020) Transcriptional regulation of Wnt\/beta-catenin pathway in colorectal cancer.\u00a0Cells 9(9)","DOI":"10.3390\/cells9092125"},{"issue":"7","key":"2291_CR17","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.97.7.3352","volume":"97","author":"AJ Rowan","year":"2000","unstructured":"Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, Bicknell D, Bodmer WF, Tomlinson IP (2000) APC mutations in sporadic colorectal tumors: a mutational \u201chotspot\u201d and interdependence of the \u201ctwo hits.\u201d Proc Natl Acad Sci USA 97(7):3352\u20133357","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4940","key":"2291_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1126\/science.2296722","volume":"247","author":"AR Moser","year":"1990","unstructured":"Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247(4940):322\u2013324","journal-title":"Science"},{"key":"2291_CR19","doi-asserted-by":"crossref","unstructured":"Washington K, Zemper AE\u00a0(2019) Apc-related models of intestinal neoplasia: a brief review for pathologists.\u00a0Surg Exp Pathol\u00a02(1)","DOI":"10.1186\/s42047-019-0036-9"},{"issue":"7\u20138","key":"2291_CR20","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/0959-8049(95)00181-H","volume":"31A","author":"AR Moser","year":"1995","unstructured":"Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, Dove WF (1995) ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 31A(7\u20138):1061\u20131064","journal-title":"Eur J Cancer"},{"issue":"38","key":"2291_CR21","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1038\/sj.onc.1203036","volume":"18","author":"J Heyer","year":"1999","unstructured":"Heyer J, Yang K, Lipkin M, Edelmann W, Kucherlapati R (1999) Mouse models for colorectal cancer. Oncogene 18(38):5325\u20135333","journal-title":"Oncogene"},{"issue":"11","key":"2291_CR22","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/jcmm.12119","volume":"17","author":"J Zhang","year":"2013","unstructured":"Zhang J, Cao H, Zhang B, Cao H, Xu X, Ruan H, Yi T, Tan L, Qu R, Song G, Wang B, Hu T (2013) Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling. J Cell Mol Med 17(11):1484\u20131493","journal-title":"J Cell Mol Med"},{"issue":"4","key":"2291_CR23","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/gut.2008.169805","volume":"59","author":"A Zilberberg","year":"2010","unstructured":"Zilberberg A, Lahav L, Rosin-Arbesfeld R (2010) Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons. Gut 59(4):496\u2013507","journal-title":"Gut"},{"issue":"4","key":"2291_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00109-015-1364-1","volume":"94","author":"M Caspi","year":"2016","unstructured":"Caspi M, Firsow A, Rajkumar R, Skalka N, Moshkovitz I, Munitz A, Pasmanik-Chor M, Greif H, Megido D, Kariv R, Rosenberg DW, Rosin-Arbesfeld R (2016) A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents. J Mol Med (Berl) 94(4):469\u2013482","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"2291_CR25","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/ijc.32557","volume":"146","author":"R Kariv","year":"2020","unstructured":"Kariv R, Caspi M, Fliss-Isakov N, Shorer Y, Shor Y, Rosner G, Brazowski E, Beer G, Cohen S, Rosin-Arbesfeld R (2020) Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli. Int J Cancer 146(4):1064\u20131074","journal-title":"Int J Cancer"},{"issue":"4","key":"2291_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1261\/rna.5147804","volume":"10","author":"KM Keeling","year":"2004","unstructured":"Keeling KM, Lanier J, Du M, Salas-Marco J, Gao L, Kaenjak-Angeletti A, Bedwell DM (2004) Leaky termination at premature stop codons antagonizes nonsense-mediated mRNA decay in S. cerevisiae. RNA 10(4):691\u2013703","journal-title":"RNA"},{"issue":"12","key":"2291_CR27","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1073\/pnas.92.12.5431","volume":"92","author":"KK McCaughan","year":"1995","unstructured":"McCaughan KK, Brown CM, Dalphin ME, Berry MJ, Tate WP (1995) Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc Natl Acad Sci USA 92(12):5431\u20135435","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2291_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/hep.22620","volume":"49","author":"AD Brinker","year":"2009","unstructured":"Brinker AD, Wassel RT, Lyndly J, Serrano J, Avigan M, Lee WM, Seeff LB (2009) Telithromycin-associated hepatotoxicity: clinical spectrum and causality assessment of 42 cases. Hepatology 49(1):250\u2013257","journal-title":"Hepatology"},{"issue":"9","key":"2291_CR29","first-page":"631","volume":"65","author":"D Guo","year":"2010","unstructured":"Guo D, Cai Y, Chai D, Liang B, Bai N, Wang R (2010) The cardiotoxicity of macrolides: a systematic review. Pharmazie 65(9):631\u2013640","journal-title":"Pharmazie"},{"issue":"6","key":"2291_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/14787210.2016.1179580","volume":"14","author":"X Li","year":"2016","unstructured":"Li X, Wang M, Liu G, Zhou L, Wang Z, Li C (2016) Macrolides use and the risk of sudden cardiac death. Expert Rev Anti Infect Ther 14(6):535\u2013537","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"2291_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/01478885.2019.1708611","volume":"43","author":"E Chlipala","year":"2020","unstructured":"Chlipala E, Bendzinski CM, Chu K, Johnson JI, Brous M, Copeland K, Bolon B (2020) Optical density-based image analysis method for the evaluation of hematoxylin and eosin staining precision. J Histotechnol 43(1):29\u201337","journal-title":"J Histotechnol"},{"issue":"3","key":"2291_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.33611\/trs.2020-014","volume":"2","author":"Y Horai","year":"2020","unstructured":"Horai Y, Akatsuka A, Mizukawa M, NiIshina H, Nishikawa S, Ono Y, Takemoto K, Mochida H (2020) Current status and prospects for quantitative analysis of digital image of pathological specimen using image processing software including artificial intelligence. Translational and Regulatory Sciences 2(3):72\u201379","journal-title":"Translational and Regulatory Sciences"},{"issue":"2","key":"2291_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pharmthera.2012.07.007","volume":"136","author":"HL Lee","year":"2012","unstructured":"Lee HL, Dougherty JP (2012) Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Ther 136(2):227\u2013266","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2291_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007898","volume":"5","author":"JL Stamos","year":"2013","unstructured":"Stamos JL, Weis WI (2013) The beta-catenin destruction complex. Cold Spring Harb Perspect Biol 5(1):a007898","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"2291_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/sj.bjc.6603873","volume":"97","author":"ML Davies","year":"2007","unstructured":"Davies ML, Roberts GT, Stuart N, Wakeman JA (2007) Analysis of a panel of antibodies to APC reveals consistent activity towards an unidentified protein. Br J Cancer 97(3):384\u2013390","journal-title":"Br J Cancer"},{"key":"2291_CR36","doi-asserted-by":"publisher","first-page":"4379673","DOI":"10.1155\/2018\/4379673","volume":"2018","author":"E Fredericks","year":"2018","unstructured":"Fredericks E, Dealtry G, Roux S (2018) Beta-catenin regulation in sporadic colorectal carcinogenesis: not as simple as APC. Can J Gastroenterol Hepatol 2018:4379673","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2291_CR37","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3389\/fonc.2019.01248","volume":"9","author":"Y Lecarpentier","year":"2019","unstructured":"Lecarpentier Y, Schussler O, Hebert JL, Vallee A (2019) Multiple targets of the canonical WNT\/beta-catenin signaling in cancers. Front Oncol 9:1248","journal-title":"Front Oncol"},{"issue":"9","key":"2291_CR38","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1128\/AAC.33.9.1419","volume":"33","author":"HA Kirst","year":"1989","unstructured":"Kirst HA, Sides GD (1989) New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrob Agents Chemother 33(9):1419\u20131422","journal-title":"Antimicrob Agents Chemother"},{"issue":"16","key":"2291_CR39","first-page":"5136","volume":"63","author":"HL Kettunen","year":"2003","unstructured":"Kettunen HL, Kettunen AS, Rautonen NE (2003) Intestinal immune responses in wild-type and Apcmin\/+ mouse, a model for colon cancer. Cancer Res 63(16):5136\u20135142","journal-title":"Cancer Res"},{"issue":"3","key":"2291_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/15476286.2017.1285480","volume":"14","author":"L Bidou","year":"2017","unstructured":"Bidou L, Bugaud O, Belakhov V, Baasov T, Namy O (2017) Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells. RNA Biol 14(3):378\u2013388","journal-title":"RNA Biol"},{"issue":"8","key":"2291_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024125","volume":"6","author":"C Floquet","year":"2011","unstructured":"Floquet C, Rousset JP, Bidou L (2011) Readthrough of premature termination codons in the adenomatous polyposis coli gene restores its biological activity in human cancer cells. PLoS ONE 6(8):e24125","journal-title":"PLoS ONE"},{"issue":"18","key":"2291_CR42","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.15252\/embj.201591739","volume":"34","author":"DJ Huels","year":"2015","unstructured":"Huels DJ, Ridgway RA, Radulescu S, Leushacke M, Campbell AD, Biswas S, Leedham S, Serra S, Chetty R, Moreaux G, Parry L, Matthews J, Song F, Hedley A, Kalna G, Ceteci F, Reed KR, Meniel VS, Maguire A, Doyle B, Soderberg O, Barker N, Watson A, Larue L, Clarke AR, Sansom OJ (2015) E-cadherin can limit the transforming properties of activating beta-catenin mutations. EMBO J 34(18):2321\u20132333","journal-title":"EMBO J"},{"key":"2291_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/567305","volume":"2011","author":"X Tian","year":"2011","unstructured":"Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, Zhao Y, Harris DC, Zheng G (2011) E-cadherin\/beta-catenin complex and the epithelial barrier. J Biomed Biotechnol 2011:567305","journal-title":"J Biomed Biotechnol"},{"issue":"7","key":"2291_CR44","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.celrep.2016.07.018","volume":"16","author":"S Sothiselvam","year":"2016","unstructured":"Sothiselvam S, Neuner S, Rigger L, Klepacki D, Micura R, Vazquez-Laslop N, Mankin AS (2016) Binding of macrolide antibiotics leads to ribosomal selection against specific substrates based on their charge and size. Cell Rep 16(7):1789\u20131799","journal-title":"Cell Rep"},{"issue":"9","key":"2291_CR45","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","volume":"43","author":"N Vazquez-Laslop","year":"2018","unstructured":"Vazquez-Laslop N, Mankin AS (2018) How macrolide antibiotics work. Trends Biochem Sci 43(9):668\u2013684","journal-title":"Trends Biochem Sci"},{"issue":"8","key":"2291_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/a-1185-8762","volume":"70","author":"N Hajimirzaei","year":"2020","unstructured":"Hajimirzaei N, Khalili NP, Boroumand B, Safari F, Pourhosseini A, Judi-Chelan R, Tavakoli F (2020) Comparative study of the effect of macrolide antibiotics erythromycin, clarithromycin, and azithromycin on the ERG1 gene expression in H9c2 cardiomyoblast cells. Drug Res (Stuttg) 70(8):341\u2013347","journal-title":"Drug Res (Stuttg)"},{"issue":"2","key":"2291_CR47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","volume":"118","author":"RE Morgan","year":"2010","unstructured":"Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW Jr, Lightfoot-Dunn R, Hamadeh HK (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci 118(2):485\u2013500","journal-title":"Toxicol Sci"},{"issue":"3","key":"2291_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11095-019-2582-y","volume":"36","author":"JL Woodhead","year":"2019","unstructured":"Woodhead JL, Yang K, Oldach D, MacLauchlin C, Fernandes P, Watkins PB, Siler SQ, Howell BA (2019) Analyzing the mechanisms behind macrolide antibiotic-induced liver injury using quantitative systems toxicology modeling. Pharm Res 36(3):48","journal-title":"Pharm Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02291-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T08:03:46Z","timestamp":1681200226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02291-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02291-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"7 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pharmacokinetic studies were performed at WuXi AppTec Laboratory Testing Division (Cranbury, NJ), which is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and compliant with the Office of Laboratory Animal Welfare (OLAW) Assurance to Conduct Public Health Service (PHS)-funded studies. Efficacy studies were conducted at the Crown Biosciences, Loughborough, UK, in compliance with the UK Animals Scientific Procedures Act 1986 (ASPA) and in line with Directive 2010\/63\/EU of the European Parliament and the Council of September 22, 2010, on the protection of animals used for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approvals"}},{"value":"All authors are employees and shareholders of Eloxx Pharmaceuticals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}